A French Multi-centric Atrial Fibrillation Catheter Ablation Survey

Observation of Outcome After Catheter Ablation of Atrial Fibrillation Clinical Trial

— FrenchAF  

Official title:

A French Multi-centric Atrial Fibrillation Catheter Ablation Survey

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT01918670
• Other study ID #: FrenchAFAblationSurvey
• Status: Active, not recruiting
• Phase: N/A
• First received: August 6, 2013
• Last updated: August 6, 2013
• Start date: November 2010
• Est. completion date: December 2013

Study information

• Verified date: August 2013
• Source: Clinique Pasteur
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: no authority.
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Atrial fibrillation is the most frequent sustained arrhythmia. Catheter ablation is a procedure that is currently used for the treatment of symptomatic atrial fibrillation patients.

We have organized a multi-centric national survey of catheter ablation of atrial fibrillation in order to have a feedback on the type of procedures being performed and the overall results (freedom of atrial fibrillation) over an average follow-up of 18 months.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 0
• Est. completion date: December 2013
• Est. primary completion date: July 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• all patients undergoing catheter ablation of atrial fibrillation or left atrial flutter

Exclusion Criteria:

• patients undergoing catheter ablation of other types of arrhythmia

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Atrial Fibrillation
• Observation of Outcome After Catheter Ablation of Atrial Fibrillation

Intervention

Procedure:
• catheter ablation of atrial fibrillation
electric pulmonary vein disconnection

Locations

Country	Name	City	State
France	Clinique Pasteur	Toulouse

Sponsors (6)

Lead Sponsor	Collaborator
Clinique Pasteur	Nouvelle Clinique Nantaise, Nantes, France, Parly 2 Medical Surgical Center (CMC), Le Chesnay, France, Rennes University Hospital, University Hospital of Grenoble, Grenoble, France, University Hospital of Rouen, Rouen, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Atrial fibrillation relapse	Documentation of atrial fibrillation relapse (symptomatic or asymptomatic) after the first 3 months after the index procedure	starting 3 months after the procedure till an average of 18months follow-up	No
Secondary	Early atrial fibrillation relapse	Documented atrial fibrillation relapse (symptomatic or asymptomatic) in the first 3 months after the index procedure	first 3 months	No